23andMe (ME) Revenue & Revenue Breakdown
23andMe Revenue Highlights
Latest Revenue (Y)
$219.64M
Latest Revenue (Q)
$60.26M
Main Segment (Y)
Consumer Services
Main Geography (Y)
UNITED STATES
23andMe Revenue by Period
23andMe Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $219.64M | -26.66% |
| 2023-03-31 | $299.49M | 10.15% |
| 2022-03-31 | $271.89M | 11.47% |
| 2021-03-31 | $243.92M | -20.15% |
| 2020-03-31 | $305.46M | -30.72% |
| 2019-03-31 | $440.90M | - |
23andMe generated $219.64M in revenue during NA 2023, up -26.66% compared to the previous quarter, and up 49.82% compared to the same period a year ago.
23andMe Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $60.26M | 36.74% |
| 2024-09-30 | $44.07M | 9.05% |
| 2024-06-30 | $40.41M | -36.88% |
| 2024-03-31 | $64.03M | 43.09% |
| 2023-12-31 | $44.75M | -10.50% |
| 2023-09-30 | $50.00M | -17.85% |
| 2023-06-30 | $60.86M | -34.11% |
| 2023-03-31 | $92.38M | 38.00% |
| 2022-12-31 | $66.94M | -11.52% |
| 2022-09-30 | $75.66M | 17.28% |
| 2022-06-30 | $64.51M | -35.85% |
| 2022-03-31 | $100.56M | 76.76% |
| 2021-12-31 | $56.89M | 3.06% |
| 2021-09-30 | $55.20M | -6.81% |
| 2021-06-30 | $59.24M | -33.13% |
| 2021-03-31 | $88.58M | 59.67% |
| 2020-12-31 | $55.48M | 7.09% |
| 2020-09-30 | $51.80M | 7.80% |
| 2020-06-30 | $48.06M | - |
23andMe generated $60.26M in revenue during Q3 2024, up 36.74% compared to the previous quarter, and up 120.53% compared to the same period a year ago.
23andMe Revenue Breakdown
23andMe Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|
| Consumer Services | $166.51M | $202.31M | $247.14M | - |
| Research Services | $23.39M | $27.50M | $67.80M | - |
| PGS | - | $167.74M | - | - |
| Therapeutics | - | - | - | - |
| Service | - | $191.82M | - | - |
| Health Care, Other | - | $34.57M | - | - |
| K I T S | - | - | $27.70M | - |
23andMe's latest annual revenue breakdown by segment (product or service), as of Mar 25: Consumer Services (87.68%), and Research Services (12.32%).
Quarterly Revenue by Product
| Product/Service | Mar 25 | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Consumer Services | $83.77M | $43.59M | $88.25M | $42.90M | $48.66M | $22.50M | $10.00M | $24.50M | $83.51M | $46.04M | $44.49M | $47.85M | - |
| Research Services | $22.78M | $481.00K | $19.65M | $1.85M | $2.90M | $3.10M | $31.30M | $43.40M | $59.30M | $17.05M | $34.00M | $39.90M | $50.60M |
| Health Care, Other | - | $6.42M | $17.69M | $7.82M | $9.06M | $11.53M | $7.67M | - | - | - | - | - | - |
| Service | - | $38.51M | $97.07M | $44.75M | $50.00M | $100.56M | $56.89M | $55.20M | - | - | - | - | - |
| PGS | - | $37.17M | $93.07M | $35.08M | $39.60M | $71.98M | $38.37M | - | - | - | - | - | - |
| Therapeutics | - | - | - | - | - | - | - | - | - | - | - | - | - |
23andMe's latest quarterly revenue breakdown by segment (product or service), as of Mar 25: Consumer Services (78.62%), and Research Services (21.38%).
23andMe Revenue Breakdown by Country
Annual Revenue by Country
| Country | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|
| UNITED KINGDOM | $28.14M | $24.28M | - | - |
| UNITED STATES | $149.16M | $180.15M | $217.24M | $192.44M |
| CANADA | $8.64M | $10.56M | $13.58M | $14.29M |
| Other Regions | $3.95M | $4.64M | $5.64M | $6.68M |
| Research Services | - | - | - | $67.80M |
23andMe's latest annual revenue breakdown by geography, as of Mar 25: UNITED STATES (78.55%), UNITED KINGDOM (14.82%), CANADA (4.55%), and Other Regions (2.08%).
Quarterly Revenue by Country
| Country | Mar 25 | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UNITED KINGDOM | $26.02M | $1.97M | - | - | - | - | - | - | - | - | - | - | - |
| CANADA | $6.63M | $2.40M | $3.46M | $2.38M | $2.56M | $2.17M | $2.87M | $2.84M | $3.04M | $5.24M | $3.06M | $2.75M | $3.24M |
| Other Regions | $2.96M | $1.03M | $1.52M | $1.01M | $1.09M | $1.01M | $1.11M | $1.24M | $1.39M | $2.13M | $1.31M | $1.51M | $1.74M |
| UNITED STATES | $113.87M | $38.67M | $55.42M | $39.22M | $42.19M | $43.33M | $46.77M | $52.55M | $48.11M | $71.73M | $41.74M | $38.61M | $40.35M |
23andMe's latest quarterly revenue breakdown by geography, as of Mar 25: UNITED STATES (76.18%), UNITED KINGDOM (17.40%), CANADA (4.43%), and Other Regions (1.98%).
23andMe Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| TMO | Thermo Fisher Scientific | $42.88B | $10.36B |
| DHR | Danaher | $23.88B | $5.94B |
| A | Agilent | $6.83B | $1.68B |
| ILMN | Illumina | $4.37B | $1.10B |
| IDXX | IDEXX Laboratories | $3.90B | $998.43M |
| WAT | Waters | $2.96B | $661.71M |
| GH | Guardant Health | $739.02M | $203.47M |
| TWST | Twist Bioscience | $312.97M | $92.79M |
| ME | 23andMe | $219.64M | $60.26M |